Survival analysis using the Kaplan–Meier plotter indicated that high RUNX1 expression was associated with shorter overall survival (OS) (n = 1061) and relapse‐free survival (RFS) (n = 1336) in CRC patients (Figure 9G,H). Here, RUNX1 is linked to colorectal carcinoma.